Overexpression of mimecan in human aortic smooth muscle cells inhibits cell proliferation and enhances apoptosis and migration

Zhang,Hui‑Jie; Wang,Jing; Liu,Hui‑Fang; Zhang,Xiao‑Na; Zhan,Ming; Chen,Feng‑Ling

doi:10.3892/etm.2015.2444

Overexpression of mimecan in human aortic smooth muscle cells inhibits cell proliferation and enhances apoptosis and migration

Authors:
- Hui‑Jie Zhang
- Jing Wang
- Hui‑Fang Liu
- Xiao‑Na Zhang
- Ming Zhan
- Feng‑Ling Chen
View Affiliations

Affiliations: Department of Endocrinology, Third People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201900, P.R. China, Shanghai Institution of Endocrinology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China
Published online on: April 22, 2015 https://doi.org/10.3892/etm.2015.2444
Pages: 187-192

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The pathogenesis of atherosclerosis is multifactorial. The proliferation and migration of vascular smooth muscle cells (VSMCs) are significant in the genesis and development of atherosclerosis plaques, and the degradation of VSMCs plays a crucial role in the process. Mimecan is a member of the Keratan sulfate family of proteoglycans, which are leucine‑rich proteoglycans. It has been demonstrated that mimecan is associated with arteriogenesis and atherosclerosis. In the present study, the effect of mimecan on the characteristics of cultured human aortic smooth muscle cells (HASMCs) was investigated. In vitro, human mimecan was stably overexpressed in HASMCs using a lentiviral system. It was observed that the proliferation rate of HASMCs transduced with mimecan was lower compared with that of control cells; overexpression of mimecan induced HASMC apoptosis. To determine the effect of mimecan on HASMC migration, a Transwell cell culture chamber and sterile cloning cylinder assays were used, and it was noted that mimecan enhanced the migration of HASMCs horizontally and vertically. These data indicated that mimecan may be involved in the pathogenesis of atherosclerosis by regulating the proliferation, apoptosis and migration of VSMCs.

View Figures

View References

1	Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801–809. 1993. View Article : Google Scholar : PubMed/NCBI
2	Lusis AJ: Atherosclerosis. Nature. 407:233–241. 2000. View Article : Google Scholar : PubMed/NCBI
3	Rakesh K and Agrawal DK: Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells. Int Immunopharmacol. 5:1487–1506. 2005. View Article : Google Scholar : PubMed/NCBI
4	Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH and Banerjee A: Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol. 283:H1455–H1461. 2002. View Article : Google Scholar : PubMed/NCBI
5	Bentz H, Chang RJ, Thompson AY, Glaser CB and Rosen DM: Amino acid sequence of bovine osteoinductive factor. J Biol Chem. 265:5024–5029. 1990.PubMed/NCBI
6	Bentz H, Nathan RM, Rosen DM, Armstrong RM, Thompson AY, Segarini PR, Mathews MC, Dasch JR, Piez KA and Seyedin SM: Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem. 264:20805–20810. 1989.PubMed/NCBI
7	Iozzo RV: The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol. 32:141–174. 1997. View Article : Google Scholar : PubMed/NCBI
8	Iozzo RV: The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem. 274:18843–18846. 1999. View Article : Google Scholar : PubMed/NCBI
9	Shanahan CM, Cary NR, Osbourn JK and Weissberg PL: Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 17:2437–2447. 1997. View Article : Google Scholar : PubMed/NCBI
10	Fernandez B, Kampmann A, Pipp F, Zimmermann R and Schaper W: Osteoglycin expression and localization in rabbit tissues and atherosclerotic plaques. Mol Cell Biochem. 246:3–11. 2003. View Article : Google Scholar : PubMed/NCBI
11	Kampmann A, Fernandez B, Deindl E, Kubin T, Pipp F, Eitenmuller I, Hoefer IE, Schaper W and Zimmermann R: The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis. Mol Cell Biochem. 322:15–23. 2009. View Article : Google Scholar : PubMed/NCBI
12	Tasheva ES, Maki CG, Conrad AH, et al: Transcription activation of bovine mimecan by p53 through an intronic DNA binding site. Biochim Biophys Acta. 1517:333–338. 2001. View Article : Google Scholar : PubMed/NCBI
13	Long CJ, Roth MR, Tasheva ES, Funderburgh M, Smit R, Conrad GW and Funderburgh JL: Fibroblast growth factor-2 promotes keratan sulfate proteoglycan expression by keratocytes in vitro. J Biol Chem. 275:13918–13923. 2000. View Article : Google Scholar : PubMed/NCBI
14	Tasheva ES: Analysis of the promoter region of human mimecan gene. Biochim Biophys Acta. 1575:123–129. 2002. View Article : Google Scholar : PubMed/NCBI
15	Park SH, Koo HJ, Sung YY and Kim HK: The protective effect of Prunella vulgaris ethanol extract against vascular inflammation in TNF-α-stimulated human aortic smooth muscle cells. BMB Rep. 46:352–357. 2013. View Article : Google Scholar : PubMed/NCBI
16	Yisireyili M, Saito S, Niwa T, et al: Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells. PLoS One. 9:e1092682014. View Article : Google Scholar : PubMed/NCBI
17	Svensson L, Oldberg A and Heinegård D: Collagen binding proteins. Osteoarthritis Cartilage. 9:(Suppl A). S23–S28. 2001. View Article : Google Scholar : PubMed/NCBI
18	Tasheva ES, Koester A, Paulsen AQ, Garrett AS, Boyle DL, Davidson HJ, Song M, Fox N and Conrad GW: Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. Mol Vis. 8:407–415. 2002.PubMed/NCBI
19	Scholz D, Ito W, Fleming I, Deindl E, Sauer A, Wiesnet M, Busse R, Schaper J and Schaper W: Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteri0genesis). Virchows Arch. 436:257–270. 2000. View Article : Google Scholar : PubMed/NCBI
20	Gu XS, Lei JP, Shi JB, Lian WL, Yang X, Zheng X and Qin YW: Mimecan is involved in aortic hypertrophy induced by sinoaortic denervation in rats. Mol Cell Biochem. 352:309–316. 2011. View Article : Google Scholar : PubMed/NCBI
21	Owens GK, Kumar MS and Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 84:767–801. 2004. View Article : Google Scholar : PubMed/NCBI
22	Gordon D, Reidy MA, Benditt EP and Schwartz SM: Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA. 87:4600–4604. 1990. View Article : Google Scholar : PubMed/NCBI
23	Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A and Gabbiani G: Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 146:1059–1064. 1995.PubMed/NCBI
24	Bauriedel G, Hutter R, Welsch U, Bach R, Sievert H and Luderitz B: Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res. 41:480–488. 1999. View Article : Google Scholar : PubMed/NCBI
25	Durand E, Mallat Z, Addad F, Vilde F, Desnos M, Guerot C, Tedgui A and Lafont A: Time courses of apoptosis and cell proliferation and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model. J Am Coll Cardiol. 39:1680–1685. 2002. View Article : Google Scholar : PubMed/NCBI
26	Galis ZS and Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 90:251–262. 2002.PubMed/NCBI
27	Bendeck MP, Zempo N, Clowes AW, Galardy RE and Reidy MA: Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 75:539–545. 1994. View Article : Google Scholar : PubMed/NCBI
28	Abedi H and Zachary I: Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc Res. 30:544–556. 1995. View Article : Google Scholar : PubMed/NCBI
29	Cho A and Reidy MA: Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res. 91:845–851. 2002. View Article : Google Scholar : PubMed/NCBI
30	Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM and Ivan E: Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res. 91:852–859. 2002. View Article : Google Scholar : PubMed/NCBI
31	Johnson JL, Dwivedi A, Somerville M, George SJ and Newby AC: Matrix metalloproteinase (MMP)-3 activates MMP-9 mediated vascular smooth muscle cell migration and neointima formation in mice. Arterioscler Thromb Vasc Biol. 31:e35–e44. 2011. View Article : Google Scholar : PubMed/NCBI
32	Zempo N, Koyama N, Kenagy RD, Lea HJ and Clowes AW: Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol. 16:28–33. 1996. View Article : Google Scholar : PubMed/NCBI
33	Haj AL, Zen A, Lafont A, Durand E, Brasselet C, Lemarchand P, Godeau G and Gogly B: Effect of adenovirus-mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts. Matrix Biol. 22:251–258. 2003. View Article : Google Scholar : PubMed/NCBI
34	Owens GK: Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 75:487–517. 1995.PubMed/NCBI
35	Somlyo AP and Somlyo AV: Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 83:1325–1358. 2003. View Article : Google Scholar : PubMed/NCBI
36	Chamley-Campbell J, Campbell GR and Ross R: The smooth muscle cell in culture. Physiol Rev. 59:1–61. 1979.PubMed/NCBI
37	Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Cayatte AJ and Mowery J: Atherosclerosis. Potential targets for stabilization and regression. Circulation. 86:III117–III123. 1992.PubMed/NCBI